PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Root alkaloid extracts inhibited breast cancer cell proliferation in vitro and reduced growth and vascularization of human glioma tumors in vivo (chicken CAM model) [PMID:23860409, PMID:24317429].
Glaucine is used as a therapeutic cough suppressant in Bulgaria and other countries [PMID:23303745].
Extracts from roots, stems, leaves, and fruit pericarps showed antibacterial activity in vitro, with root extracts being most active against Gram-positive bacteria [PMID:3241575].
Extracts of G. flavum exhibited inhibitory activity against the amyloid aggregation of α-synuclein in vitro and in neuroblastoma cells [PMID:41436290].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 34454171 (2021) — Phytochemistry and pharmacology of alkaloids from Glaucium spp. · Phytochemistry
- 2.PMID: 38415909 (2024) — Variability of Isoquinoline Alkaloid Profiles and Anticholinesterase Activities with Binding-Mode Predictions of Glaucium flavum Population. · Chemistry & biodiversity
- 3.PMID: 21168338 (2011) — Physiological responses to salinity in the yellow-horned poppy, Glaucium flavum. · Plant physiology and biochemistry : PPB
- 4.PMID: 24317429 (2013) — Identification and quantification of the main active anticancer alkaloids from the root of Glaucium flavum. · International journal of molecular sciences
- 5.PMID: 23860409 (2013) — Revealing the anti-tumoral effect of Algerian Glaucium flavum roots against human cancer cells.